r/pennystocks_No_Rules

Today’s action was wild:
Cotton (CT) surged +34.06% 📈
PayPal (PYPL) dropped -8.22% 📉
Cotton’s explosive move suggests the commodity-led inflation trade is live, while PYPL gets punished. This divergence highlights how broad equity sentiment may be missing real macro undercurrents.
Tomorrow’s U.S. PPI data will be key to watch.
Full details: https://metricshour.com/markets
What are your thoughts? Commodity rotation starting or just a one-day spike?
#Commodities #Inflation #Stocks #Macro #Trading

ALL stories eventually END, the pages are turned and the cover gets closed, done over. CRUSH thru all the hype, fluff, etc. from false advertising and marketing. Just like glue holding sesame seeds on a burger bun commercial - its misleading, false, untrue, deceptive. It does NOT pass the smell test, or taste test, or actually "cutting thru the middle" to see what is inside - test. The financing will end, there is no equity, no assets, no worth, no value . Built on fraud, house of cards, shell companies, etc.

The equity is gone, there is no ""worth"" , no value, nothing there for any banker. Even less for any common stock holder , aka , a bag holder, who will never recover anything at all. Billions upon Billions of less than worthless stocks that no one wants, from a shady, deceptive, misleading , company.

IF you ever found actual, real, honest, SALES or REVENUE quantifiable numbers ,

on the roameo units, please post, share, inform, educate any and all investors.

I call complete VOODOO on AITX for falsifying the narratives, stories, press releases

--- these guys are desperate, because, no stock sales = the doors close permanently !!!!

This is on oliver trees newest Instagram post. On the boxes behind him it shows his litteral death date. So he took his obituary and designed it before he died? If you've seen the Antarctica documentary this is nuts. If you havent. This is telling you to watch it. And the Metatech industries is crazy even the website says we will create a new oliver. I will link my other subreddit to this if possible for you guys to explore this theory more on top of this. What Do You Guys Think?

How do you KNOW you are being conned, snookered, exploited ? When companies do not use - straight forward standard terms - and instead - rely on manipulative creative accounting - to fool new investors. ALWAYS seek hard numbers, quantifiable facts, and question how and where they came from. Engage your inner brain, not your emotions.

Quantum Cyber Issues Letter to Shareholders

Capitol Hill Meetings with Rep. McCormick and Senior Officials | Pentagon City Defense Conference | Connecticut Facility Purchase Agreement in Progress | Strong Financial Position

June 22, 2026 07:30 ET | Source: Quantum Cyber

WEST PALM BEACH, Florida, June 22, 2026 (GLOBE NEWSWIRE) --

Dear Fellow Shareholders,

I am writing to update you on a series of significant developments that have taken shape over the past several weeks. Together, they reflect a company that is executing with purpose: deepening its relationships in Washington, progressing its manufacturing buildout, and operating from a position of financial strength.

Washington, D.C. Engagement: Capitol Hill and Senior Government Officials

Over the past several days, our leadership delegation traveled to Washington, D.C. for a series of high-level government engagements. I had the opportunity to meet directly with Representative Rich McCormick to discuss the evolving homeland security needs facing the United States and the role that autonomous defense technology can play in addressing them. We also held meetings with senior-ranked government officials across the fields of cyber security and homeland security.

I was joined on this delegation by members of Quantum Cyber's technology and business leadership team. These were substantive conversations, and I believe they reflect growing recognition at the federal level that domestically manufactured, AI-powered autonomous platforms are central to the United States' near-term defense and security posture. We plan to continue cultivating these relationships as we advance our platform.

Pentagon City: Defense and Military Conference

While in the Washington area, we hosted a conference at Pentagon City with military stakeholders and officials from the Department of War. These discussions centered on the operational requirements, procurement priorities, and deployment scenarios most relevant to our System-of-Systems platform. The level of engagement we received reinforces our conviction that the Company is building capabilities that are directly aligned with where federal defense spending and doctrine are headed.

Connecticut Manufacturing Facility: Advancing Toward a Definitive Purchase Agreement

As previously announced on June 8, 2026, our wholly owned subsidiary Quantum Drones Corporation signed a Letter of Intent to acquire an approximately 43,000-square-foot manufacturing facility located in Bridgeport, Connecticut, from Arcade Technology LLC for an aggregate purchase price of $3,200,000. I am pleased to report that we are actively working toward the execution of a definitive purchase agreement and are making meaningful progress in that process.

This facility, which includes industrial manufacturing equipment such as stamping presses, CNC machining centers, lathes, milling machines, surface grinders, and metal fabrication tooling, is intended to serve as the operational foundation for our domestic defense manufacturing complex. Our plans for the complex include drone airframe assembly, an 80-unit 3D-printing drone production farm, our Advanced Filament Manufacturing Division producing both standard and patented EMP-hardened composite filament, and dedicated quality assurance infrastructure. Once operational, this facility is designed to allow Quantum Cyber to deliver combat-ready autonomous systems at the scale that the Pentagon and our government customers require. We look forward to providing further updates as the transaction progresses.

Executing From Financial Strength

We have significantly strengthened our financial position following the recent receipt of over $15 million in warrant exercise proceeds in May 2026. Our capital structure is also currently debt-free, with no exercisable warrants outstanding.

Management believes the existing cash position provides sufficient runway to fund the continued build-out of our autonomous defense platform, including our disclosed technology licensing pipeline, ongoing patent prosecution, and the strategic acquisition activity currently in progress. We intend to maintain this financial discipline as we move into the next phase of the Company's development.

Closing Remarks

The past several weeks have been among the most productive in Quantum Cyber's short history as an autonomous defense company. We have engaged with the officials who shape federal defense and homeland security policy. We have hosted high-level conferences with the military and the Department of War. We are steps away from acquiring the U.S.-based manufacturing infrastructure we need to deliver hardware at scale. And we are doing all of this from a debt-free balance sheet with cash in hand.

We are building this company with urgency, with discipline, and with a clear view of where the defense procurement market is heading. Thank you for your continued confidence and support.

Sincerely,
David Lazar
Chief Executive Officer
Quantum Cyber N.V. (Nasdaq: QUCY)

Forward-Looking Statements

Certain statements made in this letter are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements reflect the current analysis of existing information and are subject to various risks and uncertainties. The signing of a Letter of Intent does not guarantee the execution of a definitive purchase agreement or the consummation of the proposed transaction, and there can be no assurance that the transaction will close on the terms described or at all. As a result, caution must be exercised in relying on forward-looking statements. Due to known and unknown risks, actual results may differ materially from the Company's expectations or projections. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: (i) the failure to execute a definitive purchase agreement or satisfy closing conditions for the Connecticut facility; (ii) the failure to meet projected development and operational targets; (iii) changes in applicable laws or regulations; (iv) an inability to successfully execute on the Company's acquisition and technology pipeline; and (v) other risks and uncertainties discussed from time to time in other reports and public filings with the Securities and Exchange Commission (the "SEC") by the Company. The Company's SEC filings are available publicly on the SEC's website at www.sec.gov. Any forward-looking statement made in this letter speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, except as required by law.

Investor Relations Contact
Arx Investor Relations
North American Equities Desk
qucy@arxhq.com

https://www.globenewswire.com/news-release/2026/06/22/3315200/0/en/Quantum-Cyber-Issues-Letter-to-Shareholders.html

Seegnal Successfully Initiates First U.S. Pilot Program

Pilot now underway with U.S.-based long-term care provider following the previously announced letter of intent

CALGARY, AB, June 19, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Company"), a developer of innovative healthcare technology focused on mitigating medication risks, is pleased to announce that it has successfully initiated its first pilot program in the U.S., following the letter of intent, announced on May 19, 2026.

The pilot program is being conducted with a U.S.-based long-term care provider and is expected to run between 8 and 12 weeks from the receipt of data, followed by a potential extended evaluation period.

Approximately 1.2 million Americans live in CMS-certified nursing facilities,¹ a population characterized by advanced age, multiple chronic conditions, and high rates of polypharmacy. Adverse drug events are a significant and often preventable source of hospitalization in this population: an estimated 99,628 emergency hospitalizations each year in U.S. adults aged 65 and older are attributable to adverse drug events.²

"Initiating this pilot is an important step in executing on our U.S. commercial strategy," said Elad Bibi-Aviv, Chief Executive Officer of Seegnal. "Long-term care is a setting where medication complexity, polypharmacy, and the need for individualized prescribing decisions converge. These are areas where our platform was designed to add value." "We look forward to working with our pilot partner and to reporting on progress in due course."

About Seegnal

Seegnal Inc. (TSXV: SEGN) is an innovative healthcare technology company dedicated to reducing medication-related harm where care begins. The Company's SaaS-based clinical decision support platform is designed to help clinicians prescribe with greater precision by integrating patient-specific data at the point of care, including medications, laboratory results, renal function, allergies, age, and other relevant risk factors. By delivering more targeted, context-aware medication alerts within existing clinical workflows, Seegnal aims to reduce alert fatigue, support safer prescribing, and advance a more personalized standard of patient care. Seegnal's technology is deployed across healthcare settings and is used by more than 15,000 clinicians in daily practice. For additional Company information, please visit https://www.seegnal.com/ and follow us on LinkedIn.

Company Contact:
Elad Bibi-Aviv
Chief Executive Officer
+1 (929) 248 4652

Investor Relations Contact:
North American Equities Desk
seegnal@arxhq.com

Forward-Looking Information

This news release includes certain "forward-looking information" as defined under applicable Canadian securities legislation, including statements regarding the plans, intentions, beliefs, and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding: the conduct, scope, duration, and outcomes of the pilot of Seegnal's clinical decision support platform; the potential for an extended evaluation period or any subsequent commercial agreement; and the Company's U.S. commercial expansion strategy. Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Such risks and uncertainties include, without limitation: the pilot may be paused, suspended, modified, or terminated; the pilot may not be completed on the anticipated timeline or at all; technical, integration, data-availability, clinician-participation, regulatory, and privacy-related conditions may not continue to be satisfied; the pilot may not produce the clinical, operational, or economic outcomes contemplated; the parties may not enter into an extended evaluation or any subsequent commercial agreement; and the Company's broader U.S. commercial expansion may proceed more slowly than anticipated, or not at all. Accordingly, readers should not place undue reliance on forward-looking information, which speaks only as of the date of this news release. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

¹ KFF, "A Look at Nursing Facility Characteristics in 2025," December 17, 2025. Available at: https://www.kff.org/medicaid/a-look-at-nursing-facility-characteristics/

² Budnitz DS, Lovegrove MC, Shehab N, Richards CL. "Emergency Hospitalizations for Adverse Drug Events in Older Americans." New England Journal of Medicine. 2011;365(21):2002-2012. Available at: https://www.nejm.org/doi/full/10.1056/NEJMsa1103053

https://www.globenewswire.com/news-release/2026/06/19/3314728/0/en/Seegnal-Successfully-Initiates-First-U-S-Pilot-Program.html

Despite what all the fluff, noise, marketing, advertising NONSENSE from the incessant 8 k releases attempting to influence Yahoo Finance, NewsWire, etc. - the AITX company is very PONZI like - shady - deceptive and rips off investors.